Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
See Latest ArticlesExtending treatment after liver transplant may benefit patients with hepatitis C recurrence
EurekAlert, 11/02/09
Extending hepatitis C treatment for liver transplant patients beyond current practice results in high rates of clearance of the hepatitis C virus from the blood. The study looked at 241 consecutive liver transplant patients from 1999–2006. Patients were offered treatment if they tested positive hepatitis C, had recurrent hepatitis C with at least Stage I fibrosis on biopsy, and stable immunosuppression for a minimum of three months. Patients received either non–pegylated interferon tiw or pegylated interferon weekly in combination with ribavirin.
Today in Popular Press...keeping you current
Receive free subspecialty "5-minute updates" via email
Imaging cuts in Medicare fee schedule: An access catastrophe and danger to patients
EurekAlert, 11/03/09
To eat less, your body may want you to eat slowly
Reuters, 11/10/09
Daily dose of color may boost immunity this flu season
EurekAlert, 11/04/09
Sponsor
Article Search
Sponsor